'Forever Chemicals' Identified in Reusable Feminine Hygiene Products
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

FRIDAY, July 25, 2025 -- Reusable feminine hygiene products often contain per- and polyfluoroalkyl substances (PFAS), according to a study published online July 22 in Environmental Science & Technology Letters.
Alyssa Wicks, Ph.D., from the University of Notre Dame in Indiana, and colleagues examined PFAS content in reusable feminine hygiene products in the United States and abroad. Fifty-nine reusable feminine hygiene products across five product categories underwent total fluorine screening via particle-induced gamma-ray emission spectroscopy.
The researchers found the greatest rates of intentional PFAS use (>110 ppm total fluorine) for period underwear and reusable pads (33 and 25 percent, respectively). Nineteen of these products were chosen for a targeted analysis of 31 ionic and 11 neutral PFAS; 100 percent of the extracted products had PFAS, with the most abundant compounds 6:2 and 8:2 fluorotelomer alcohols. Tested products were sourced from North America, South America, and Europe, all of which had one or more item with levels consistent with intentional fluorination. At least one product in each category did not contain intentional fluorine.
"Since reusable products are on the rise due to their increased sustainability compared to single-use products, it's important to ensure that these products are safe," coauthor Marta Venier, Ph.D., from Indiana University in Bloomington, said in a statement. "This is crucial, especially for adolescents and young women, who are more vulnerable to potential negative health effects."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-26 06:00
Read more

- Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer
- Firefighters at Higher Risk for Many Cancers
- Shorla Oncology Announces FDA Orphan Drug Designation for SH-110 to Treat Rare Brain Cancer Using Oral Liquid
- 440 Deaths in Los Angeles County Reported Due to January 2025 Wildfires
- GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
- Fast Walking Pace Linked to Reduced Mortality
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions